Wreghitt, TG (December 1993)
doi:10.3390/nu7095388 DiNicolantonio JJ, et al
The available data is one short-duration clinical trial in surgical patients (which found it well tolerated) and early pharmacokinetic work in healthy volunteers that did not flag acute harms
Best peptides for muscle growth and preservation require adequate protein intake and resistance training, but the metabolic environment created by tirzepatide appears more muscle-sparing than traditional caloric restriction
That can introduce variability such as: Mislabeling Contamination Inconsistent dosing Unknown impurities Side effects: what we can responsibly say Because robust human safety data are limited, it's hard to give a definitive side-effect profile with meaningful incidence rates
Wegovy and Mounjaro are both weekly injections used for weight management, but they contain different active ingredients and work through slightly different hormone pathways